AI-Powered Collaboration: AstraZeneca and CSPC partner to develop novel oral therapies for chronic and immunological diseases affecting over two billion people globally. High-Value Deal Structure: ...

AstraZeneca's lengthy and turbulent development of CTLA4 inhibitor tremelimumab has at least led to a regulatory approval as part of a combination therapy for advanced liver cancer. Tremelimumab ...

AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for chronic conditions. The strategic research collaboration will focus on the ...

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

Gombe Police impound 327 motorcycles & tricycles in a major crackdown on traffic violations and criminal activities. Nighttime curfew violations and unauthorized modifications were among the offenses.

Review the current valuation for AstraZeneca PLC ADR (AZN:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

An interactive map from the Wilderness Society highlights the tracts of US Forest Service and Bureau of Land Management lands that could go up for sale if the Senate's version of the budget bill ...

See the latest AstraZeneca PLC ADR stock price (AZN:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

A federal prosecutor said Vance Boelter went to the homes of four politicians in a deadly rampage in Minnesota on Saturday.

・AstraZeneca’s EOI could mark a significant step toward establishing a multi-stakeholder platform focused on enhancing the reliability, interpretability, and regulatory alignment of AI-driven ...

The Currencies Heat Map is a set of tables which display the relative strengths of major currency pairs in comparison with each other.

Bristol Myers Squibb’s new multibillion-dollar partnership in a hot area of cancer research overshadowed many of the announcements at the recent annual meeting of the American Society of ...